Mostrando 2 resultados de: 2
Chimeric antigen receptor T-cell therapy: A narrative review of the literature
ArticleAbstract: Chimeric antigen receptor T cell (CAR-T) therapy is one of the most advanced forms of immunotherapy.Palabras claves:Adoptive cell therapy, adoptive immunotherapy, Chimeric antigen receptor therapy, genetic engineering, Hematology, T-LymphocytesAutores:John A. Cuenca, Ketty E. Vera, Schettino M.G., Tamariz L.E.Fuentes:scopusCritical Care Admission of an HIV Patient with Diabetic Ketoacidosis Secondary to Pembrolizumab
ArticleAbstract: Background. Pembrolizumab is a checkpoint inhibitor that targets the programmed cell death-1 receptoPalabras claves:Autores:Botz G.H., John A. Cuenca, Laserna A., Nates J.L., Reyes M.P.Fuentes:scopus